OMER
OMEROS CORP
NASDAQ · Healthcare · Biotechnology · US
$17.87
−3.14%Forward multiples
Based on analyst estimates
- P/E forward
- 8.02x
- P/E 2026E
- 20.30x
- P/E 2027E
- 18.06x
- P/E 2028E
- 11.34x
- P/S forward
- 3.25x
Trailing multiples
Trailing twelve months
- P/E TTM
- 9.36x
- PEG TTM
- 0.57x
- Price / book
- -25.19x
- Price / sales
- 33.67x
- Price / cash flow
- -18.84x
Enterprise value
- Enterprise value
- $1.2B
- EV / sales
- 32.41x
- EV / EBITDA
- 9.15x
- EV / EBIT
- -17.10x
- Market cap
- $1.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026